These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11382716)

  • 1. Administration and clearance of amphotericin B during high-efficiency or high-efficiency/high-flux dialysis.
    Gussak HM; Rahman S; Bastani B
    Am J Kidney Dis; 2001 Jun; 37(6):E45. PubMed ID: 11382716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy.
    Fourtounas C; Marangos M; Kalliakmani P; Savidaki E; Goumenos DS; Vlachojannis JG
    Nephrol Dial Transplant; 2006 Jan; 21(1):236-7. PubMed ID: 16263742
    [No Abstract]   [Full Text] [Related]  

  • 3. Peritonitis caused by Monilia sitophila in a patient undergoing peritoneal dialysis.
    Radix AE; Bieluch VM; Graeber CW
    Int J Artif Organs; 1996 Apr; 19(4):218-20. PubMed ID: 8786172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis.
    Phillips I; Eykyn S; MacGregor GA; Jones NF
    Clin Nephrol; 1973; 1(4):271-2. PubMed ID: 4593451
    [No Abstract]   [Full Text] [Related]  

  • 5. Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.
    Wood JE; Mahnensmith MP; Mahnensmith RL; Perazella MA
    Am J Med Sci; 2004 Jan; 327(1):5-8. PubMed ID: 14722389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes.
    Goldie SJ; Kiernan-Tridle L; Torres C; Gorban-Brennan N; Dunne D; Kliger AS; Finkelstein FO
    Am J Kidney Dis; 1996 Jul; 28(1):86-91. PubMed ID: 8712227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
    Kleinpeter MA; Butt AA
    Adv Perit Dial; 2001; 17():176-9. PubMed ID: 11510270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida peritonitis complicating peritoneal dialysis: successful treatment with low dose amphotericin B therapy.
    Mandell IN; Ahem MJ; Kliger AS; Andriole VT
    Clin Nephrol; 1976 Nov; 6(5):492-6. PubMed ID: 991471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B therapy in an anephric patient.
    Feldman HA; Hamilton JD; Gutman RA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):302-5. PubMed ID: 4586143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Candida peritonitis by peritoneal lavage with amphotericin B.
    Bortolussi RA; MacDonald MR; Bannatyne RM; Arbus GS
    J Pediatr; 1975 Dec; 87(6 Pt 1):987-8. PubMed ID: 1102642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal treatment of Candida peritonitis in continuous ambulatory peritoneal dialysis patients.
    Struijk DG; Krediet RT; Boeschoten EW; Rietra PJ; Arisz L
    Am J Kidney Dis; 1987 Jan; 9(1):66-70. PubMed ID: 3812482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.
    Block ER; Bennett JE; Livoti LG; Klein WJ; MacGregor RR; Henderson L
    Ann Intern Med; 1974 May; 80(5):613-7. PubMed ID: 4823813
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Candida despite seemingly adequate systemic and intraperitoneal amphotericin B treatment in a patient on CAPD.
    Bastani B; Westervelt FB
    Am J Kidney Dis; 1986 Oct; 8(4):265-6. PubMed ID: 3766532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fungal peritonitis in patients on peritoneal dialysis].
    Wojtaszek E; Ostrowski G; Niemczyk S; Lange J; Grzejszczak A; Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 2006 Jul; 116(1):678-82. PubMed ID: 17340975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal infection with multiple species of Candida: a case report.
    Islam S; Zaidi AK; Wilson J
    Surg Infect (Larchmt); 2002; 3(1):35-7. PubMed ID: 12593698
    [No Abstract]   [Full Text] [Related]  

  • 17. Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
    Muther RS; Bennett WM
    Proc Clin Dial Transplant Forum; 1979; 9():100-1. PubMed ID: 552029
    [No Abstract]   [Full Text] [Related]  

  • 18. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
    Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
    J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B.
    Sedlacek M; Cotter JG; Suriawinata AA; Kaneko TM; Zuckerman RA; Parsonnet J; Block CA
    Am J Kidney Dis; 2008 Feb; 51(2):302-6. PubMed ID: 18215708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.
    Knoppert DC; Salama HE; Lee DS
    Ann Pharmacother; 2001 Sep; 35(9):1032-6. PubMed ID: 11573851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.